Published in BMJ on November 18, 1989
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ (2000) 3.10
Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43
Breast cancer and NSAID use: a meta-analysis. Br J Cancer (2001) 2.21
Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer (1999) 1.85
Neuropsychological data in nondemented oldest old: the 90+ Study. J Clin Exp Neuropsychol (2007) 1.63
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res (2008) 1.52
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer (2004) 1.44
Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol (2007) 1.28
Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer (1999) 1.23
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. Am J Epidemiol (2011) 1.22
Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. J Cancer Res Clin Oncol (2003) 1.20
Aspirin and lung cancer in women. Br J Cancer (2002) 1.18
Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev (2008) 1.17
Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol (2014) 1.15
Regular aspirin use and lung cancer risk. BMC Cancer (2002) 1.15
Smoking and mortality among residents of a California retirement community. Am J Public Health (1994) 1.15
PADB: published association database. BMC Bioinformatics (2007) 1.12
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. BMC Med (2014) 1.12
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II. Arch Intern Med (2009) 1.10
Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS One (2011) 1.07
Nonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysis. Can Urol Assoc J (2009) 1.07
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04
Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. Am J Epidemiol (2010) 1.02
Aspirin and colorectal cancer. BMJ (1993) 1.00
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. Br J Cancer (2012) 0.96
Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer (2013) 0.96
Use of NSAIDs, smoking and lung cancer risk. Br J Cancer (2007) 0.95
Aspirin use and lung cancer in men. Br J Cancer (2003) 0.95
Aspirin and colorectal cancer. Br J Cancer (1997) 0.94
Aspirin and urologic cancer risk: an update. Nat Rev Urol (2012) 0.91
Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk. World J Surg Oncol (2014) 0.86
Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study. J Thorac Oncol (2012) 0.85
Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours. Int J Exp Pathol (2002) 0.85
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study. Breast Cancer Res (2010) 0.85
Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst (2008) 0.84
Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies. PLoS One (2013) 0.83
Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2011) 0.82
Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 0.82
Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England. Int J Cancer (2012) 0.80
Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks? Ther Adv Drug Saf (2012) 0.78
A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study. Cancer Causes Control (2013) 0.77
Nonhormonal drugs and cancer. Environ Health Perspect (1995) 0.77
Use of acetylsalicylic acid by physicians and in the community. CMAJ (1991) 0.77
Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. CMAJ (1993) 0.76
Aspirin use and chronic diseases. BMJ (1990) 0.75
Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer. Pharmaceuticals (Basel) (2010) 0.75
Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis. PLoS One (2015) 0.75
Does aspirin affect the rate of cataract formation? Cross-sectional results during a randomised double-blind placebo controlled trial to prevent serious vascular events. UK-TIA Study Group. Br J Ophthalmol (1992) 0.75
[Epidemiological studies for evaluating the role of cyclooxygenase in chemoprevention of malignant tumors]. Wien Med Wochenschr (2003) 0.75
The analysis of rates using Poisson regression models. Biometrics (1983) 6.94
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J (1974) 3.80
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst (1984) 2.17
Aspirin and cataract. Lancet (1986) 2.02
Aspirin and bleeding peptic ulcers in the elderly. BMJ (1988) 2.00
Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut (1985) 1.47
A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer (1976) 1.32
Aspirin and gastrointestinal haemorrhage: a methodologic assessment. J Chronic Dis (1985) 1.21
Etiology of cancer of the renal pelvis. J Natl Cancer Inst (1983) 1.20
Senile cataracts: evidence for acceleration by diabetes and deceleration by salicylate. Can J Ophthalmol (1981) 1.07
Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol (1983) 1.05
Aspirin and senile cataracts in rheumatoid arthritis. Lancet (1981) 1.05
Lack of evidence for aspirin use and prevention of cataracts. Arch Ophthalmol (1987) 1.02
Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res (1989) 0.99
Analgesics and cancer of the renal pelvis in New South Wales. Cancer (1982) 0.94
XXIV International Congress of Ophthalmology and 1982 annual meeting of the American Academy of Ophthalmology. October 30-November 5, 1982. Scientific sessions. Ophthalmology (1982) 0.86
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
piwi encodes a nucleoplasmic factor whose activity modulates the number and division rate of germline stem cells. Development (2000) 4.54
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Seasonal variation in suicides: diminished or vanished. Experience from England and Wales, 1982-1996. Br J Psychiatry (2000) 3.70
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med (1995) 2.83
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
Toward the primary prevention of cancer. Science (1991) 2.41
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev (2001) 2.17
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Estrogens and breast cancer. Carcinogenesis (1996) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol (1971) 2.04
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol (2001) 2.02
Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics (1976) 2.00
Smoking, air pollution, and the high rates of lung cancer in Shenyang, China. J Natl Cancer Inst (1989) 1.99
Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet (2000) 1.98
Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res (1986) 1.98
Yellow fever immunity surveys in northern Uganda and Kenya and eastern Somalia, 1966-67. Bull World Health Organ (1968) 1.96
Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology (1991) 1.96
Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst (1986) 1.95
Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer (1987) 1.91
Aromatase and breast cancer susceptibility. Endocr Relat Cancer (1999) 1.89
Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol (2008) 1.89
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.85
The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res (1995) 1.84
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77
Conservation of function between mammalian and plant steroid 5alpha-reductases. Proc Natl Acad Sci U S A (1997) 1.75
N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res (1982) 1.70
The epidemiology of endometrial cancer in young women. Br J Cancer (1983) 1.70
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev (2000) 1.69
Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst (2001) 1.69
Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res (1988) 1.68
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst (1986) 1.66
Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev (1997) 1.64
Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res (1982) 1.64
Smoking and other risk factors for lung cancer in women. J Natl Cancer Inst (1985) 1.63
Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg (1972) 1.60